Total Payments
$240,589
2024 Payments
$19,680
Companies
30
Transactions
672
Medicare Patients
690
Medicare Billing
$41,893
Payment Breakdown by Category
Other$155,302 (64.6%)
Travel$48,249 (20.1%)
Consulting$25,104 (10.4%)
Food & Beverage$11,934 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $155,302 | 138 | 64.6% |
| Travel and Lodging | $48,249 | 274 | 20.1% |
| Consulting Fee | $25,104 | 12 | 10.4% |
| Food and Beverage | $11,934 | 248 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $70,391 | 242 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $47,619 | 133 | $0 (2020) |
| UROVANT SCIENCES INC | $46,033 | 98 | $0 (2022) |
| Mylan Specialty L.P. | $26,538 | 51 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $22,460 | 40 | $0 (2024) |
| Mylan Inc. | $12,056 | 15 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $6,762 | 14 | $0 (2023) |
| Theravance Biopharma Inc. | $4,416 | 6 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $2,785 | 8 | $0 (2017) |
| Amgen Inc. | $268.66 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,680 | 39 | Mylan Specialty L.P. ($11,571) |
| 2023 | $28,198 | 89 | Sumitomo Pharma America, Inc. ($14,577) |
| 2022 | $39,484 | 96 | UROVANT SCIENCES INC ($37,406) |
| 2021 | $20,654 | 31 | Mylan Inc. ($8,932) |
| 2020 | $12,835 | 33 | Lilly USA, LLC ($9,177) |
| 2019 | $49,354 | 157 | Lilly USA, LLC ($19,426) |
| 2018 | $44,894 | 148 | Lilly USA, LLC ($33,185) |
| 2017 | $25,489 | 79 | Sunovion Pharmaceuticals Inc. ($18,034) |
All Payment Transactions
672 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,327.38 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $1,079.69 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Travel and Lodging | Cash or cash equivalent | $158.04 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | Cash or cash equivalent | $66.18 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | Cash or cash equivalent | $18.89 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 11/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $87.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $433.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $324.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Oncology | ||||||
| 04/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,515.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Travel and Lodging | Cash or cash equivalent | $4.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $433.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,920.00 | General |
| 03/14/2024 | Sumitomo Pharma America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $86.93 | General |
| 03/14/2024 | Sumitomo Pharma America, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.55 | General |
| 02/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,732.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,299.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $119.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 150 | 210 | $18,090 | $7,359 |
| 2022 | 7 | 191 | 286 | $24,205 | $10,699 |
| 2021 | 3 | 107 | 203 | $17,135 | $8,349 |
| 2020 | 9 | 242 | 430 | $42,940 | $15,486 |
Total Patients
690
Total Services
1,129
Medicare Billing
$41,893
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,600 | $2,336 | 64.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 50 | $6,500 | $2,294 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $2,550 | $1,506 | 59.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 73 | $730.00 | $613.20 | 84.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $630.00 | $329.58 | 52.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 34 | 34 | $4,080 | $279.87 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 55 | $7,150 | $3,513 | 49.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 47 | 59 | $7,080 | $2,879 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $2,400 | $1,648 | 68.7% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 25 | 38 | $3,420 | $1,369 | 40.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 17 | 19 | $2,850 | $806.76 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 92 | $920.00 | $272.67 | 29.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 11 | 11 | $385.00 | $210.42 | 54.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 78 | $10,140 | $5,326 | 52.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 39 | 52 | $6,240 | $2,807 | 45.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 38 | 73 | $755.00 | $216.00 | 28.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 76 | 162 | $19,440 | $5,481 | 28.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 93 | $12,090 | $4,477 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,400 | $1,494 | 62.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 18 | 22 | $1,760 | $1,287 | 73.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $2,100 | $1,003 | 47.8% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 13 | 15 | $2,250 | $637.73 | 28.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 16 | 16 | $1,440 | $459.10 | 31.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 25 | $750.00 | $442.01 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 34 | 71 | $710.00 | $206.58 | 29.1% |
About Dr. Manuel Suarez Barcelo, MD
Dr. Manuel Suarez Barcelo, MD is a Internal Medicine healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669461042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Suarez Barcelo, MD has received a total of $240,589 in payments from pharmaceutical and medical device companies, with $19,680 received in 2024. These payments were reported across 672 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($155,302).
As a Medicare-enrolled provider, Suarez Barcelo has provided services to 690 Medicare beneficiaries, totaling 1,129 services with total Medicare billing of $41,893. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location North Miami, FL
- Active Since 10/18/2005
- Last Updated 02/20/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669461042
Products in Payments
- GEMTESA (Drug) $66,460
- TRULICITY (Drug) $56,526
- LONHALA MAGNAIR (Drug) $25,518
- Yupelri (Drug) $18,950
- YUPELRI (Drug) $11,571
- UTIBRON (Drug) $10,521
- BROVANA (Drug) $10,359
- GVOKE HYPOPEN (Drug) $6,762
- Wixela Inhub (Drug) $3,124
- APTIOM (Drug) $990.00
- Kerendia (Drug) $247.91
- REXULTI (Drug) $154.08
- Prolia (Biological) $120.28
- HUMALOG (Drug) $114.57
- Cologuard Collection Kit (Device) $74.82
- Nuedexta (Drug) $71.70
- NUEDEXTA (Drug) $69.93
- AREXVY (Drug) $69.72
- Aimovig (Biological) $69.23
- ENTRESTO (Drug) $58.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Miami
Sheren Leung, D.o, D.O
Internal Medicine — Payments: $12,126
Internal Medicine $12,126
Dr. Gilbert Leung, M.d, M.D
Internal Medicine — Payments: $8,321
Internal Medicine $8,321
Dr. Nasiruddin Nazarally, M.d, M.D
Internal Medicine — Payments: $6,825
Internal Medicine $6,825
Dr. Luis Perez, D.o, D.O
Internal Medicine — Payments: $5,990
Internal Medicine $5,990
Eliades Carmenate, M.d, M.D
Internal Medicine — Payments: $5,003
Internal Medicine $5,003
Hamidreza Moghaddam, M.d, M.D
Internal Medicine — Payments: $4,735
Internal Medicine $4,735